Corporate News 28-Jan-23
Board of Aarti Drugs recommends interim dividend
Of Rs 1 per share
Aarti Drugs announced that the Board of Directors of the Company at its meeting held on 27 January 2023, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.
Previous News
Aarti Drugs consolidated net profit rises 37.54% in the June 2023 quarter
( Results - Announcements 22-Jul-23 07:42 )
Aarti Drugs to convene board meeting
( Corporate News - 16-Jul-25 10:24 )
Aarti Drugs consolidated net profit rises 7.12% in the March 2022 quarter
( Results - Announcements 09-May-22 16:46 )
Aarti Drugs to table results
( Corporate News - 14-Oct-22 11:40 )
Aarti Drugs to discuss results
( Corporate News - 24-Apr-23 11:53 )
Aarti Drugs to convene board meeting
( Corporate News - 15-Jul-23 09:43 )
Aarti Drugs reappoints Rashesh Gogri as MD for 5 years
( Hot Pursuit - 27-Sep-22 09:20 )
Aarti Drugs AGM scheduled
( Corporate News - 03-Sep-24 11:38 )
Aarti Drugs fixes record date for buyback of shares
( Market Beat - Reports 19-Mar-21 16:34 )
Aarti Drugs to table results
( Corporate News - 18-Jan-24 15:14 )
Aarti Drugs slips for second day
( Hot Pursuit - 15-Dec-21 13:01 )
Other Stories
Board of Wipro recommends interim dividend
17-Jul-25 15:54
Board of Navkar Corporation approves shifting of corporate office
17-Jul-25 15:51
Board of Newgen Software Technologies approves allotment of 53,600 equity shares under ESOP
17-Jul-25 15:49
Board of Patanjali Foods approves bonus issue of 2:1
17-Jul-25 15:48
Bharti Airtel partners with Perplexity
17-Jul-25 15:22
RateGain successfully deploys Rev-AI for Green Motion South Africa
17-Jul-25 15:17
Sterlite Technologies commissions its first green hydrogen facility for optical fibre
17-Jul-25 15:11
Satin Creditcare Network opens its first branch in Aizawl, Mizoram
17-Jul-25 15:08
Zigly sets up its experience center facility at Khar West, Mumbai
17-Jul-25 15:04
Kilburn Engineering receives orders worth Rs 36 cr
17-Jul-25 14:53
Back
Top